|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/095 | (2019.01) |
| A61P 1/16 | (2018.01) | ||
| A61K 38/08 | (2019.01) | ||
| A61P 1/00 | (2018.01) | ||
| C07K 7/16 | (2006.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/00 | (2006.01) |
| (11) | Patento numeris | 3347032 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16818751.6 |
| Europos patento paraiškos padavimo data | 2016-06-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/040284 |
| Data | 2016-06-30 |
| (87) | Numeris | WO 2017/004317 |
| Data | 2017-01-05 |
| (30) | Numeris | Data | Šalis |
| 201562186638 P | 2015-06-30 | US | |
| 201562267510 P | 2015-12-15 | US | |
| 201662321558 P | 2016-04-12 | US |
| (72) |
ANGELI, Paolo , IT
MARKHAM, Penelope , US
ADAMS, Jonathan , US
|
| (73) |
BioVie Inc. ,
680 W. Nye Lane
Suite 204, Carson City, NV 89703,
US
|
| (54) | TERLIPRESSIN FOR THE TREATMENT OF ASCITES DUE TO LIVER CIRRHOSIS ADMINISTERED AS A CONTINUOUS INFUSION |
| TERLIPRESSIN FOR THE TREATMENT OF ASCITES DUE TO LIVER CIRRHOSIS ADMINISTERED AS A CONTINUOUS INFUSION |